OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
17.33
+0.93 (5.67%)
At close: Aug 13, 2025, 4:00 PM
18.08
+0.75 (4.33%)
Pre-market: Aug 14, 2025, 8:54 AM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $321.73 million as of August 14, 2025. Its market cap has increased by 64.57% in one year.
Market Cap
321.73M
Enterprise Value
334.12M
1-Year Change
64.57%
Ranking
Category
Stock Price
$17.33
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $321.73M, an increase of 840.74%. That is a compound annual growth rate of 36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 304.50M | 240.22% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |